https://www.zacks.com/stock/news/2287811/wall-street-analysts-think-fiverr-fvrr-is-a-good-investment-is-it?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2287811
Jun 13, 2024 - Based on the average brokerage recommendation (ABR), Fiverr (FVRR) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
zc:239544404019663372
0
https://www.zacks.com/stock/news/2287810/kla-klac-is-considered-a-good-investment-by-brokers-is-that-true?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2287810
Jun 13, 2024 - The average brokerage recommendation (ABR) for KLA (KLAC) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
zc:4885096134329477364
0
https://www.zacks.com/stock/news/2287714/what-makes-cadeler-cdlr-a-good-fit-for-trend-investing?cid=CS-ZC-FT-tale_of_the_tape|recent_price_strength_screen-2287714
Jun 13, 2024 - Cadeler (CDLR) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
zc:-7068723901610550769
0
https://seekingalpha.com/article/4698972-evg-a-good-choice-for-income-but-may-underperform-a-regular-bond-fund?source=feed_tag_etf_portfolio_strategy
Jun 12, 2024 - Eaton Vance Short Duration Diversified Income Fund offers high yield, strong price performance, leverage for yield boost. Click for my EVG CEF update.
0
sa:-310898273376877699
0
https://www.zacks.com/stock/news/2287491/snap-on-s-sna-growth-strategies-seem-good-apt-to-hold?cid=CS-ZC-FT-analyst_blog|rank_focused-2287491
Jun 12, 2024 - Snap-on's (SNA) performance benefits from strategic initiatives, such as enhancing the franchise network, cost-control efforts and increasing brand awareness.
zc:-2415985668891544845
0
https://seekingalpha.com/news/4115228-cerevel-therapeutics-gains-after-abbvie-says-making-good-progress-with-ftc?source=feed_sector_healthcare
Jun 12, 2024 - Financial writer reports 1.5% rise in Cerevel Therapeutics (CERE) after Abbvie (ABBV) reaffirms planned acquisition timeline and progress with FTC review.
0
sa:-8816007864951678281
0
https://www.zacks.com/stock/news/2287106/what-makes-red-violet-rdvt-a-good-fit-for-trend-investing?cid=CS-ZC-FT-tale_of_the_tape|recent_price_strength_screen-2287106
Jun 12, 2024 - If you are looking for stocks that are well positioned to maintain their recent uptrend, Red Violet (RDVT) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
zc:-8472564476567623627
0
https://www.zacks.com/stock/news/2286569/teekay-tankers-tnk-is-considered-a-good-investment-by-brokers-is-that-true?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2286569
Jun 11, 2024 - Based on the average brokerage recommendation (ABR), Teekay Tankers (TNK) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
zc:4098968131373693728
0
https://www.zacks.com/stock/news/2286568/wall-street-analysts-think-adma-biologics-adma-is-a-good-investment-is-it?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2286568
Jun 11, 2024 - Based on the average brokerage recommendation (ABR), Adma Biologics (ADMA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
zc:5336074757710459996
0
https://www.zacks.com/stock/news/2286571/wall-street-analysts-think-ardmore-shipping-asc-is-a-good-investment-is-it?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2286571
Jun 11, 2024 - According to the average brokerage recommendation (ABR), one should invest in Ardmore Shipping (ASC). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
zc:-6286199806725475967
0